Early rapid eye movement sleep behavior disorder predicts incident cognitive impairment in Parkinson's disease across ages
- PMID: 37037069
- PMCID: PMC10928909
- DOI: 10.1016/j.parkreldis.2023.105392
Early rapid eye movement sleep behavior disorder predicts incident cognitive impairment in Parkinson's disease across ages
Abstract
This study demonstrated possible rapid eye movement sleep behavior disorder (RBD)'s relationship to longitudinal, incident cognitive impairment in the Parkinson's Progression Markers Initiative (PPMI) database. Age did not moderate this relationship, suggesting that RBD serves as a cognitive risk factor across individuals of all ages with recently diagnosed Parkinson's disease.
Keywords: Cognition; Parkinson's disease; Rapid eye movement sleep behavior disorder; Risk factors; Survival analyses.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest None.
Figures

Comment in
-
Role of rapid eye movement sleep behavior disorder (RBD) and other clinical factors in the prediction of cognitive impairment in Parkinson's disease.Parkinsonism Relat Disord. 2023 Sep;114:105415. doi: 10.1016/j.parkreldis.2023.105415. Epub 2023 Apr 29. Parkinsonism Relat Disord. 2023. PMID: 37142470 No abstract available.
References
-
- Chahine LM, Xie SX, Simuni T, Tran B, Postuma R, Amara A, Oertel WH, Iranzo A, Scordia C, Fullard M, Linder C, Purri R, Darin A, Rennert L, Videnovic A, Del Riva P, Weintraub D, Longitudinal changes in cognition in early Parkinson’s disease patients with REM sleep behavior disorder, Parkinsonism Relat Disord. 27 (2016) 102–106. 10.1016/j.parkreldis.2016.03.006. - DOI - PMC - PubMed
-
- Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Simuni T, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, Weintraub D, Foroud T, Tosun-Turgut D, Poston K, Arnedo V, Frasier M, Sherer T, Bressman S, Merchant M, Poewe W, Kopil C, Naito A, Dorsey R, Casaceli C, Daegele N, Albani J, Uribe L, Foster E, Long J, Seedorff N, Crawford K, Smith D, Casalin P, Malferrari G, Halter C, Heathers L, Russell D, Factor S, Hogarth P, Amara A, Hauser R, Jankovic J, Stern M, Hu S-C, Todd G, Saunders-Pullman R, Richard I, Saint-Hilaire H, Seppi K, Shill H, Fernandez H, Trenkwalder C, Oertel W, Berg D, Brockman K, Wurster I, Rosenthal L, Tai Y, Pavese N, Barone P, Isaacson S, Espay A, Rowe D, Brandabur M, Tetrud J, Liang G, Iranzo A, Tolosa E, Marder K, de Sanchez M, Stefanis L, Marti M, Martinez J, Corvol J-C, Assly O, Brillman S, Giladi N, Smejdir D, Pelaggi J, Kausar F, Rees L, Sommerfield B, Cresswell M, Blair C, Williams K, Zimmerman G, Guthrie S, Rawlins A, Donharl L, Hunter C, Tran B, Darin A, Venkov H, Thomas C-A, James R, Heim B, Deritis P, Sprenger F, Raymond D, Willeke D, Obradov Z, Mule J, Monahan N, Gauss K, Fontaine D, Szpak D, McCoy A, Dunlop B, Payne L, Ainscough S, Carvajal L, Silverstein R, Espay K, Ranola M, Rezola E, Santana H, Stamelou M, Garrido A, Carvalho S, Kristiansen G, Specketer K, Mirlman A, Facheris M, Soares H, Mintun A, Cedarbaum J, Taylor P, Jennings D, Slieker L, McBride B, Watson C, Montagut E, Sheikh Z, Bingol B, Forrat R, Sardi P, Fischer T, Reith D, Egebjerg J, Larsen L, Breysse N, Meulien D, Saba B, Kiyasova V, Min C, McAvoy T, Umek R, Iredale P, Edgerton J, Santi D, Czech C, Boess F, Sevigny J, Kremer T, Grachev I, Merchant K, Avbersek A, Muglia P, Stewart A, Prashad R, Taucher J, The Parkinson’s progression markers initiative (PPMI) – establishing a PD biomarker cohort, Ann. Clin. Transl. Neurol 5 (2018) 1460–1477. 10.1002/acn3.644. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical